摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-1-[(2R,5R)-5-azido-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one

中文名称
——
中文别名
——
英文名称
4-amino-1-[(2R,5R)-5-azido-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one
英文别名
——
4-amino-1-[(2R,5R)-5-azido-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one化学式
CAS
——
化学式
C10H14N6O4
mdl
——
分子量
282.26
InChiKey
DEUZIURSVQYVJZ-SYCPKDDISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    123
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • Phosphoramidate Derivatives of Nucleosides
    申请人:Centocor Ortho Biotech Products L.P.
    公开号:EP2166016A1
    公开(公告)日:2010-03-24
    Compounds of formula I : R1 is hydrogen, C1-C4alkyl, OH, C1-C4alkoxy; R2 is phenyl, optionally substituted with 1, 2 or 3 substituents each independently selected from halo, C1-C6alkyl, and C1-C6alkoxy, or R2 is naphtalenyl; R3 is hydrogen, C1-C6alkyl, benzyl; R4 is hydrogen, C1-C6alkyl, benzyl; or R3 and R4 together with the carbon atom to which they are attached form C3-C7cycloalkyl; R5 is C1-C6alkyl, benzyl, or phenyl, optionally substituted with 1, 2 or 3 substituents each independently selected from hydroxy, C1-C6alkoxy, amino, mono- and diC1-C6alkylamino; or a pharmaceutically acceptable salt or solvate thereof; useful in the prophylaxis or treatment of HCV infections.
    公式I的化合物:R1是氢、C1-C4烷基、羟基、C1-C4烷氧基;R2是苯基,可选地取代有1、2或3个取代基,每个取代基独立选择自卤素、C1-C6烷基和C1-C6烷氧基,或者R2是基;R3是氢、C1-C6烷基、苄基;R4是氢、C1-C6烷基、苄基;或者R3和R4与它们连接的碳原子一起形成C3-C7环烷基;R5是C1-C6烷基、苄基或苯基,可选地取代有1、2或3个取代基,每个取代基独立选择自羟基、C1-C6烷氧基、基、单烷基和双烷基基;或其药学上可接受的盐或溶剂;用于预防或治疗丙型肝炎感染。
  • HCV NUCLEOSIDE INHIBITOR
    申请人:Medivir AB
    公开号:EP2084175A1
    公开(公告)日:2009-08-05
  • Antiviral nucleosides
    申请人:Johansson Nils-Gunnar
    公开号:US20080152621A1
    公开(公告)日:2008-06-26
    4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
  • ANTIVIRAL NUCLEOSIDES
    申请人:Kalyanov Genadiy
    公开号:US20100130735A1
    公开(公告)日:2010-05-27
    4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C(HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
  • US7666856B2
    申请人:——
    公开号:US7666856B2
    公开(公告)日:2010-02-23
查看更多